- $16.14bn
- $18.71bn
- $8.25bn
Icon jumps after third-quarter profit beat
ICON's Q3 adj EPS and adj EBITDA beat analyst expectations
Icon Plc Expected To Post Earnings Of $2.60 A Share: Earnings Preview
Icon Plc Reports Results For The Quarter Ended June 30: Earnings Summary
Clinical research firm ICON's Q2 revenue rises 1.2%, beats analyst estimates
Icon Plc Expected To Post Earnings Of $2.51 A Share: Earnings Preview
U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Micron
U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Forte Biosciences
U.S. STOCKS ON THE MOVE-Levi's, Meta, PepsiCo
U.S. STOCKS ON THE MOVE-Levi, Ionis Pharmaceuticals, Gloo Holdings
TD Cowen sees improving demand for contract research firms in Q2 2026
Ireland's ICON Q1 results beat estimates on commercial momentum
Brief: ICON Schedules First Quarter 2026 Earnings Conference Call
Icon Plc Reports Results For The Quarter Ended December 31: Earnings Summary
Brief: Icon Expands Us Early Phase Research Capabilities With New Clinic And Outpatient Centres
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy
U.S. STOCKS ON THE MOVE-ICON, Old Dominion, Energy companies
U.S. STOCKS ON THE MOVE-Phillips 66, Cognizant, AbbVie
ICON climbs as audit probe finds revenue overstatement within limits